RankingsPricing
  1. US-listed companies
  2. MIMEDX GROUP, INC.
  3. Financials
  4. Research & development

MIMEDX GROUP, INC.MDXG

Market cap
$1B
P/E ratio
SummaryFinancials
Period EndResearch & development (Million USD)YoY (%)
Dec 31, 202412-2.56%
Dec 31, 202313-44.52%
Dec 31, 202223+31.62%
Dec 31, 202117+48.05%
Dec 31, 202012+5.16%
Dec 31, 201911-29.34%
Dec 31, 201816+30.96%
Dec 31, 201612+43.09%
Dec 31, 20158+19.33%
Dec 31, 20147+45.56%
Dec 31, 20135+67.91%
Dec 31, 20123+10.83%
Dec 31, 20113

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)